T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis

European Journal of Immunology

Volumn 29, Issue 10, 1999, Pages 3140-3147

  Cross, Anne H ^a   Lyons, Jeri A ^a   San, Manuel ^a   Keeling, Richard M ^a   Ku, Grace ^a   Racke, Michael K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Cellular activation; Co stimulation; Experimental autoimmune encephalomyelitis; T lymphocyte

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOCYTE ANTIGEN RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; IMMUNOCONJUGATES; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; T-LYMPHOCYTES;

EID: 0032842355     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199910)29:10<3140::AID-IMMU3140>3.0.CO;2-W     Document Type: Article

References (36)

1. Zamvil, S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R. and Steinman, L., T cell clones specific for myelin basic protein induce chronic relapsing paralyses and demyelination. Nature 1985. 317: 355-358.
2. Hickey, W. F., Hsu, B. L. and Kimura, H., T-lymphocyte entry into the central nervous system. J. Neurosci Res. 1991. 28: 254-260.
3. Mueller, D. L., Jenkins, M. K. and Schwartz, R. H., Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 1989. 7: 445-480.
4. Weaver, C. T. and Unanue, E., The costimulatory function of antigen-presenting cells. Immunol. Today 1990. 11: 49-55.
5. Jenkins, M., Chen, K., Jung, C. A., Mueller, D. L. and Schwartz, R. H., Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 1990. 144: 16-22.
6. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P., CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992. 356: 607-610.
7. + T lymphocytes from TCR transgenic mice. J. Immunol. 1994. 152: 5220-5225.
8. Ando, D. G., Clayton, J., Kono, D., Urban, J. L. and Sercarz, E. E., Encephalito-genic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th1 lymphokine subtype. Cell. Immunol. 1989. 124: 132-143.
9. + mature thymocytes. J. Immunol. 1990. 144: 1646-1653.
10. Gross, J. A., Callas, E. and Allison, J. P., Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 1992. 149: 380-388.
11. Miller, S. C., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandakar, N. J., Dal Canto, M. C. and Bluestone, J. A., Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 1995. 3: 793-745.
12. Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M. and Khoury, S., Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 1998. 161: 1104-1112.
13. Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., Muramatsu, S., Hoes, R. J. and Steinman, R. M., The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 1994. 180: 1849-1860.
14. Chuang, E., Alegre, M. L., Duckett, C. S., Noel, P. J., Vander Heiden, M. G. and Thompson, C. B., Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 1997. 159: 144-151.
15. + T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (transcostimulation). Eur. J. Immunol. 1994. 24: 859-866.
16. Azuma, M., Ysell, H., Phillips, J. H., Spits, H. and Lanier, L. L., Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 1993. 177: 845-850.
17. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Hodes R. J., Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 1994. 180: 631-640.
18. Boehme, S. A., Zheng, L. and Lenardo, M. J., Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T lymphocyte death. J. Immunol. 1995. 155: 1703-1712.
19. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 1990. 63: 162-170.
20. + T cells differing in CD45R expression. J. Immunol. 1992. 149: 2300-2306.
21. Sagerstrom, C. G., Kerr, E. M., Allison, J. P. and Davis, M. M., Activation and differentiation requirements of primary T cells in vitro. Proc. Natl. Acad. Sci. USA 1993. 90: 8987-8991.
22. McCarron, R. M., Fallis, R. J. and McFarlin, D. E., Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 1990. 29: 73-79.
23. Perry, L. L., Barzaga-Gilbert, E. and Trotter, J. L., T cell sensitization to proteolipid protein in myelin basic protein-induced experimental allergic encephalomyelitis. J. Neuroimmunol. 1991. 33: 7-11.
24. Lehmann, P. V., Forsthuber, T., Miller, A. and Sercarz, E. E., Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992. 358: 155-157.
25. Cross, A. H., Tuohy, V. K. and Raine, C. S., Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol. 1993. 146: 261-269.
26. McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C. and Miller, S. D., Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 1995. 182: 75-85.
27. Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., Gray, G. S., Thompson, C. B. and June, C. H., Characterization of CTLA-4 structure and expression on human Tcells. J. Immunol. 1993. 151: 3489-3499.
28. Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A. and Peach, R., Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994. 1: 793-801.
29. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Greeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405-413.
30. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
31. Blair, P. J., Riley, J. L., Levine B. L., Lee, K. P., Craighead, N., Francomano, T., Perfetoo, S. J., Gray, G. S., Carreno, B. M. and June, C. H., CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J. Immunol. 1998. 160: 12-15.
32. Perrin, P. L., Maldonado, J. H., Davis, T. A., June, C. H. and Racke, M. K., CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 1996. 157: 1333-1336.
33. Karandikar, N. J., Vaderlugt, C. L., Walunas, T. L, Miller, S. D. and Bluestone, J. A., CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 1996. 184: 783-788.
34. Greenfield, E. A., Howard, E., Paradis, T., Nguyen, K., Benazzo, F., McLean, P., Hollsberg, P., Davis, G., Hafler, D. A., Sharpe, A. H., Freeman, G. J. and Kuchroo, V. K., B7.2 expressed by T cells does not induce CD28 mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J. Immunol. 1997. 158: 2025-2034.
35. Cross, A. H., Manning, P. T., Stern, M. K. and Misko, T. P., Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol. 1997. 80: 121-130.
36. Bourdette, D. N., Vainiene, M., Morrison, W., Jones, R., Turner, M. J., Hashim, G. A., Vandenbark, A. A. and Offner, H., Myelin basic protein specific T cell lines and clones derived from the CNS of rats with EAE only recognize encephalitogenic epitopes. J. Neurosci Res. 1991. 30: 308-315.